AstraZeneca Cancer Drug Shows Early Signs of Promise in Covid-19
Source: Bloomberg By Cristin Flanagan and Suzi Ring A small study in 19 people suggested a drug from AstraZeneca Plc’s arsenal of cancer treatments may be repurposed to help Covid-19 patients experiencing extreme immune reactions. Many patients with Covid-19 suffer from an inflammatory condition, sometimes called cytokine storm, when the immune system overreacts […]